Guidelines & Statements

Study: 6 in 10 US Adults Eligible for CKM Drugs

Radcliffe CVRM

Broadcast

Cardiovascular Renal Metabolic

Guidelines & Statements
Targeting Residual Inflammatory Risk

Smeeta Sinha, Ramzi Y. J. Khamis, Daniel Bromage, et al

Watch time: 1h 3m 57s
New Horizons in Dyslipidaemia 2026

Radcliffe CVRM

Tirzepatide Noninferior to Dulaglutide for CV Events

Radcliffe CVRM

Albuminuria Change Validated as CKD Surrogate Endpoint

Radcliffe CVRM

BMI Affects NT-proBNP Risk Stratification in HFpEF

Radcliffe Cardiology

New BP Guideline Adopts PREVENT Risk Assessment

Radcliffe Cardiology

Intensive BP Lowering Improves Retinal Microvasculature

Radcliffe CVRM

Nir Uriel

Watch time: 34m 39s (5 videos)
ESC 25 Guidelines Discussion: Management of Dyslipidaemias

Harriette Van Spall, Jeanine Roeters Van Lennep

Watch time: 14m 3s
Intensive Blood Pressure Control Shows Net Clinical Benefit Despite Increased Adverse Events

Radcliffe CVRM

FDA Approves Finerenone for Heart Failure with LVEF ≥40%

Radcliffe Cardiology

New Horizons in Dyslipidaemia 2026

Radcliffe CVRM

Giulio Balestrieri, Raul Limonta, Enrico Ponti, et al

Read time: 18m 10s

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
ESC 25 Guidelines Discussion: Management of Dyslipidaemias

Harriette Van Spall, Jeanine Roeters Van Lennep

Watch time: 14m 3s

Broadcast

Cardiovascular Renal Metabolic

Guidelines & Statements
Targeting Residual Inflammatory Risk

Smeeta Sinha, Ramzi Y. J. Khamis, Daniel Bromage, et al

Watch time: 1h 3m 57s

Broadcast

Cardiovascular Renal Metabolic

Guidelines & Statements
Targeting Residual Inflammatory Risk

Smeeta Sinha, Ramzi Y. J. Khamis, Daniel Bromage , et al

Watch time: 1h 3m 57s
2023 ESC Guidelines Update: Acute & Chronic Heart Failure

Giuseppe Rosano, Harriette Van Spall

Watch time: 10m 8s

Harriette Van Spall, Clyde W Yancy

Watch time: 1h 1m 16s (8 videos)

Nir Uriel

Watch time: 34m 39s (5 videos)
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
New BP Guideline Adopts PREVENT Risk Assessment

Radcliffe Cardiology

About

Guidelines and recommendations are designed to guide physicians in making decisions in daily practice. They provide a condensed, graded summary of all available evidence at the time of writing, allowing clinicians to make evidence-based choices for their patients.

Media

ESC 25 Guidelines Discussion: Management of Dyslipidaemias

Harriette Van Spall, Jeanine Roeters Van Lennep

Watch time: 14m 3s

Broadcast

Cardiovascular Renal Metabolic

Guidelines & Statements
Targeting Residual Inflammatory Risk

Smeeta Sinha, Ramzi Y. J. Khamis, Daniel Bromage , et al

Watch time: 1h 3m 57s

Broadcast

Cardiovascular Renal Metabolic

Guidelines & Statements
Targeting Residual Inflammatory Risk

Smeeta Sinha, Ramzi Y. J. Khamis, Daniel Bromage, et al

Watch time: 1h 3m 57s

Nir Uriel

Watch time: 34m 39s (5 videos)

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
Lifestyle Interventions for Treatment and Remission of T2D and Pre-diabetes

Richard Rosenfeld

Watch time: 9m 30s

Paola Fioretto, Rajiv Agarwal

Watch time: 28m 13s (3 videos)
Masterclass: Evidence on the Use of SGLT2is in HF Across the EF Spectrum

Scott Solomon, Harriette Van Spall, Mikhail Kosiborod, et al

Watch time: 29m 37s
2023 ESC Guidelines Update: Acute & Chronic Heart Failure

Giuseppe Rosano, Harriette Van Spall

Watch time: 10m 8s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s

Articles

New Insights on HFpEF Treatment

Giulio Balestrieri

,

Raul Limonta

,

Enrico Ponti

,

Anna Merlo

,

Edoardo Sciatti

,

Salvatore D’Isa

,

Mauro Gori

,

Gavino Casu

,

Cristina Giannattasio

,

Michele Senni

,

Emilia D’Elia

,

Published:

03 April 2024

Citation:

Cardiac Failure Review 2024;10:e05.

DOI:

https://doi.org/10.15420/cfr.2023.13
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 9183
  • Downloads: Downloads 1007
  • Citations: 9
  • Read time: 18m 10s